Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
09/2010
09/16/2010WO2010068287A8 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010US20100234425 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
09/16/2010US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
09/16/2010US20100234229 Substituted Spirocyclic Ketoenols
09/16/2010CA2754941A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP1910314B1 Benzimidazole derivatives for treatment of inflammatory diseases
09/15/2010CN101830855A Substituted nitrogen-containing benzoheterocycle compounds and preparation method and application thereof
09/15/2010CN101830854A Substituted phenylhydrazones compounds, preparation method and application thereof
09/15/2010CN101830767A Method for synthesizing difluoromethyl compound
09/14/2010US7795446 Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
09/14/2010US7795445 Hyperglycemia, type 2 diabetes, atherosclerosis and other blood sugar disorders; use in combination with other antidiabetic, antilipemic agents; N-[2-(3-Aminopropylsulfanyl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]benzamide trifluoroacetic acid salt for example
09/14/2010US7795250 Indole derivatives as antiviral agents
09/10/2010WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/10/2010CA2753149A1 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
09/08/2010EP2225210A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
09/08/2010CN101827827A 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors
09/08/2010CN101318934B 2'-oxatyl-4'fluorine biphenyl heterocycle ketone compound, preparation and application thereof
09/08/2010CN101235017B Method for preparing benzimidazole
09/07/2010US7790904 Substituted benzimidazole derivatives
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010US20100222591 New Compounds
09/02/2010US20100222345 Novel compounds as antagonists or inverse agonists for opioid receptors
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2222645A2 Benzimidazole derivatives and their use as fxr agonists
09/01/2010CN101817787A Androgen receptor antagonist for resisting prostate cancer
08/2010
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786103 Method for isolating an intestinal cholesterol binding protein
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/25/2010CN101812021A Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781595 Benzimidazole derivatives: preparation and pharmaceutical applications
08/24/2010US7781165 by using 3-ethyl-1-[4-(3-ethyl-3H-benzimidazol-1-ium)-but-1-yl]3H-benzimidazol-1-ium or 3-methyl-1-[4-(3-methyl-3H-benzimidazol-1-ium)-but-1-yl]3H-benzimidazol-1-ium; decreasing nonspecific hybridization
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010US20100210846 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1H-benzimidazoles and the intermediate compounds used therein
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210701 Novel Forms of Bendamustine Free Base
08/19/2010US20100210699 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/18/2010EP2217577A2 Novel compounds and compositions and methods of use
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101805330A 2-alkyl-benzimidazole-1-acetyl hydrazone and synthesis method and application thereof
08/18/2010CN101805328A epothilone derivatives
08/18/2010CN101805297A Preparation method of 2-alkyl-benzimidazolyl-1-acetate
08/18/2010CN101804047A Antimicrobial and radioprotective compounds
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776900 gamma--aminobutyric acid A (GABAA) receptor modulators such as 1-[3-(Pyridin-2-ylmethoxymethyl)-phenyl]-1H-benzoimidazole-5-carboxylic acid ethyl ester, useful in the treatment of central nervous system diseases and disorders; anxiolytic agents; side effect reduction
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2407208C Process for producing optically active sulfoxide derivative
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/11/2010CN201543258U Distillation apparatus of naphthol AS-BI recovered solvent
08/11/2010CN101798320A Gasochromic rare earth complex and preparation method and application thereof
08/11/2010CN101798287A [(4-methyl-2-propyl-N-methoxyl-substituted benzene alkyl-1H-benzimidazole-6-formamide)-1-yl] methyldiphenyl compound and preparation method thereof
08/11/2010CN101318933B Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof
08/11/2010CN101120057B Phthalocyanine compound, process for producing the same and colored composition containing the phthalocyanine compound
08/11/2010CN101115802B Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
08/10/2010US7772267 Bicyclic modulators of androgen receptor function
08/10/2010US7772248 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
08/10/2010US7772232 Quinazolinyl compounds as inhibitors of potassium channel function
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100193773 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
08/04/2010EP1874737B1 Substituted 2-aminoalkylthio-benzimidazoles and use thereof for reducing blood sugar levels
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/03/2010CA2425165C A process for the preparation of bis-benzazolyl compounds
07/2010
07/29/2010WO2010085377A2 Hydroxamic acid derivatives
07/29/2010WO2010084852A1 Light-emitting element material and light-emitting element
07/29/2010WO2010044585A3 Piperidine compounds, pharmaceutical composition comprising the same and its use
07/29/2010WO2010006238A3 Stimulus-responsive apta-chelamers
07/29/2010US20100190826 Benzimidazole derivative
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/29/2010DE102009005746A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
07/28/2010CN101786991A Substituted tetracycline compounds
07/22/2010WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083276A1 Novel forms of bendamustine free base
07/22/2010WO2010081670A2 Process for the preparation of benzimidazoles
07/22/2010WO2010012745A3 Benzimidazoles
07/22/2010US20100184993 Compound having hydantoin ring and method of producing the same
07/22/2010US20100184982 Detergent-dispersant, additive composition for lubricant, and lubricant composition
07/22/2010US20100184794 Fused heterocyclic compound
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183531 Stable soluble salts of phenylbenzimidazole sulfonic acid at phs at or below 7.0
07/22/2010CA2749101A1 Novel forms of bendamustine free base
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 154